| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.006 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.33 | 0.007 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |